School of Pharmacy
Peter W. Taylor has not added Biography.
If you are Peter W. Taylor and would like to personalize this page please email our Author Liaison for assistance.
Methicillin resistance in Staphylococcus aureus: mechanisms and modulation.
Science progress , 2002 | Pubmed ID: 11969119
Expression, mutagenesis and kinetic analysis of recombinant K1E endosialidase to define the site of proteolytic processing and requirements for catalysis.
Molecular microbiology May, 2002 | Pubmed ID: 11994155
New ways to treat bacterial infections.
Drug discovery today Nov, 2002 | Pubmed ID: 12546840
Structural pharmacogenomics: the answer to antimicrobial drug resistance?
Drug discovery today Feb, 2003 | Pubmed ID: 12568777
Antimycobacterial activity of indigenous South African plants.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde Dec, 2003 | Pubmed ID: 14750489
Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype.
Antimicrobial agents and chemotherapy May, 2004 | Pubmed ID: 15105097
Modulation of beta-lactam resistance in Staphylococcus aureus by catechins and gallates.
International journal of antimicrobial agents May, 2004 | Pubmed ID: 15120724
In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria.
International journal of antimicrobial agents Jun, 2004 | Pubmed ID: 15194133
Anti-Staphylococcus aureus activity and oxacillin resistance modulating capacity of 3-O-acyl-catechins.
International journal of antimicrobial agents Oct, 2004 | Pubmed ID: 15380264
Synthesis and antibacterial activity of hydrolytically stable (-)-epicatechin gallate analogues for the modulation of beta-lactam resistance in Staphylococcus aureus.
Bioorganic & medicinal chemistry letters May, 2005 | Pubmed ID: 15863332
Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase.
The Journal of antimicrobial chemotherapy Jul, 2005 | Pubmed ID: 15914489
Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria.
The Journal of antimicrobial chemotherapy Sep, 2005 | Pubmed ID: 16024592
Towards rational treatment of bacterial infections during extended space travel.
International journal of antimicrobial agents Sep, 2005 | Pubmed ID: 16118047
Potentiation of catechin gallate-mediated sensitization of Staphylococcus aureus to oxacillin by nongalloylated catechins.
Antimicrobial agents and chemotherapy Feb, 2006 | Pubmed ID: 16436737
Single-blind randomized trial of combination antibiotic therapy in rheumatoid arthritis.
The Journal of rheumatology Feb, 2006 | Pubmed ID: 16465651
Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane.
Current medical research and opinion Mar, 2006 | Pubmed ID: 16574043
Epicatechin gallate, a component of green tea, reduces halotolerance in Staphylococcus aureus.
International journal of food microbiology Oct, 2006 | Pubmed ID: 16839636
Interactions of pyrrolobenzodiazepine dimers and duplex DNA from methicillin-resistant Staphylococcus aureus.
International journal of antimicrobial agents Jun, 2007 | Pubmed ID: 17350809
The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus.
Microbiology (Reading, England) Jul, 2007 | Pubmed ID: 17600054
Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1.
Microbiology (Reading, England) Aug, 2008 | Pubmed ID: 18667585
Disruption of D-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the {beta}-lactam resistance modifier (-)-epicatechin gallate.
The Journal of antimicrobial chemotherapy Jun, 2009 | Pubmed ID: 19307172
Asymmetric total synthesis of B-ring modified (-)-epicatechin gallate analogues and their modulation of beta-lactam resistance in Staphylococcus aureus.
Tetrahedron Aug, 2005 | Pubmed ID: 19330042
Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer.
The Journal of antimicrobial chemotherapy Nov, 2009 | Pubmed ID: 19744983
Antimicrobial properties of green tea catechins.
Food science and technology bulletin , 2005 | Pubmed ID: 19844590
Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1.
Microbiology (Reading, England) Jul, 2010 | Pubmed ID: 20395269
Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated beta-lactam resistance by delocalizing PBP2.
The Journal of biological chemistry Jul, 2010 | Pubmed ID: 20516078
Pharmaceutical quality of nine generic orlistat products compared with Xenical(r).
Obesity facts Aug, 2010 | Pubmed ID: 20823686
The minor groove-binding agent ELB-21 forms multiple interstrand and intrastrand covalent cross-links with duplex DNA and displays potent bactericidal activity against methicillin-resistant Staphylococcus aureus.
The Journal of antimicrobial chemotherapy May, 2011 | Pubmed ID: 21393142
Anti-staphylococcal activity and β-lactam resistance attenuating capacity of structural analogues of (-)-epicatechin gallate.
Bioorganic & medicinal chemistry letters Dec, 2011 | Pubmed ID: 22030031
Increase in Campylobacter jejuni invasion of intestinal epithelial cells under low-oxygen coculture conditions that reflect the in vivo environment.
Infection and immunity May, 2012 | Pubmed ID: 22354027
Antistaphylococcal activity of DNA-interactive pyrrolobenzodiazepine (PBD) dimers and PBD-biaryl conjugates.
The Journal of antimicrobial chemotherapy Jul, 2012 | Pubmed ID: 22547662
Symmetric bis-benzimidazoles are potent anti-staphylococcal agents with dual inhibitory mechanisms against DNA gyrase.
Biochemistry Jul, 2012 | Pubmed ID: 22746203
Biopharmaceutical challenges of therapeutics in space: formulation and packaging considerations.
Therapeutic delivery Nov, 2011 | Pubmed ID: 22826869
Transcriptome analysis of responses to rhodomyrtone in methicillin-resistant Staphylococcus aureus.
PloS one , 2012 | Pubmed ID: 23029218
Poly-γ-(D)-glutamic acid capsule interferes with lytic infection of Bacillus anthracis by B. anthracis-specific bacteriophages.
Applied and environmental microbiology Jan, 2013 | Pubmed ID: 23124233
Draft Genome Sequences of Pseudomonas fluorescens BS2 and Pusillimonas noertemannii BS8, Soil Bacteria That Cooperate To Degrade the Poly-γ-d-Glutamic Acid Anthrax Capsule.
Genome announcements Jan, 2013 | Pubmed ID: 23405351
Alternative natural sources for a new generation of antibacterial agents.
International journal of antimicrobial agents Sep, 2013 | Pubmed ID: 23796893
Altered innate defenses in the neonatal gastrointestinal tract in response to colonization by neuropathogenic Escherichia coli.
Infection and immunity Sep, 2013 | Pubmed ID: 23798529
Antibacterial activity of head-to-head bis-benzimidazoles.
International journal of antimicrobial agents Oct, 2013 | Pubmed ID: 23837928
A poly-γ-(D)-glutamic acid depolymerase that degrades the protective capsule of Bacillus anthracis.
Molecular microbiology Mar, 2014 | Pubmed ID: 24428662
Staphylococcal phenotypes induced by naturally occurring and synthetic membrane-interactive polyphenolic β-lactam resistance modifiers.
PloS one , 2014 | Pubmed ID: 24699700
Improved synthesis of structural analogues of (-)-epicatechin gallate for modulation of staphylococcal β-lactam resistance.
Tetrahedron May, 2014 | Pubmed ID: 24876661
Surfactant-free purification of membrane protein complexes from bacteria: application to the staphylococcal penicillin-binding protein complex PBP2/PBP2a.
Nanotechnology Jul, 2014 | Pubmed ID: 24972373
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유